Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Geriatrics

• Publication date

  2006-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 17112309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides

  2005cited by this paper
• Relationship between time of intake of grapefruit juice and its effect on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects

  2004cited by this paper
• Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin.

  2004cited by this paper
• Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone

  2004cited by this paper
• Grapefruit Juice-fluvoxamine Interaction: Is It Risky Or Not?

  2003cited by this paper
• Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice

  2003cited by this paper
• Principles of drug therapy for the elderly patient.

  2003cited by this paper
• The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.

  2002cited by this paper
• Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine

  2002cited by this paper
• Effects of grapefruit juice on the pharmacokinetics of sildenafil

  2002cited by this paper
• Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds.

  2001cited by this paper
• The effects of grapefruit juice on the pharmacokinetics of erythromycin

  2001cited by this paper
• Effect of Grapefruit Juice on the Pharmacokinetics of Losartan and Its Active Metabolite E3174 in Healthy Volunteers

  2001cited by this paper
• Effect of grapefruit juice on digoxin pharmacokinetics in humans

  2001cited by this paper
• Effect of grapefruit juice dose on grapefruit juice–triazolam interaction: repeated consumption prolongs triazolam half-life

  2000cited by this paper
• Grapefruit juice–felodipine interaction in the elderly

  2000cited by this paper
• Relationship between time after intake of grapefruit juice and the effect on pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects

  2000cited by this paper
• Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

  2000cited by this paper
• Influence of grapefruit juice on scopolamine pharmacokinetics and pharmacodynamics in healthy male and female subjects.

  2000cited by this paper
• Dramatic inhibition of amiodarone metabolism induced by grapefruit juice.

  2000cited by this paper
• Drug-grapefruit juice interactions.

  2000cited by this paper
• Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin

  1999cited by this paper
• OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.

  1999cited by this paper
• Grapefruit Juice Activates P-Glycoprotein-Mediated Drug Transport

  1999cited by this paper
• Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.

  1999cited by this paper
• The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study.

  1999cited by this paper
• 6′,7′‐Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P‐glycoprotein

  1999cited by this paper
• Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid

  1998cited by this paper
• Grapefruit juice and the response to warfarin.

  1998cited by this paper
• Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice.

  1998cited by this paper
• Effect of grapefruit juice on carbamazepine bioavailability in patients with epilepsy

  1998cited by this paper
• Effect of age on pharmacokinetics and pharmacodynamics in man.

  1998cited by this paper
• Grapefruit juice substantially increases plasma concentrations of buspirone

  1998cited by this paper
• Drug Interactions with Grapefruit Juice

  1998cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997cited by this paper
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997cited by this paper
• Effects of grapefruit juice ingestion – pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

  1997cited by this paper
• Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction.

  1997cited by this paper
• Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.

  1996cited by this paper
• Effect of Grapefruit Juice on the Pharmacokinetics and Pharmacodynamics of Quinidine in Healthy Volunteers

  1996cited by this paper
• Effect of grapefruit juice on the pharmacokinetics of amlodipine in healthy volunteers

  1996cited by this paper
• Can grapefruit juice influence ethinylestradiol bioavailability?

  1996cited by this paper
• Interaction between grapefruit juice and midazolam in humans

  1995cited by this paper
• Effect of grapefruit juice on blood cyclosporin concentration.

  1995cited by this paper
• Enzyme induction in the cytochrome P-450 system.

  1990cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper

• Review of drug-drug interactions in patients with prostate cancer

  2024cites this paper
• Extraction, Characterization, and Biological Activity of Volatile and Non-volatile Components of Grapefruit

  2024influential citation
• Interactions between nutraceuticals/nutrients and nutrients and therapeutic drugs

  2021cites this paper
• Naringenin Release to Biomembrane Models by Incorporation into Nanoparticles. Experimental Evidence Using Differential Scanning Calorimetry

  2021cites this paper
• İLAÇLARLA ETKİLEŞİM POTANSİYELİNE SAHİP HAYVAN SAĞLIĞINDA DA KULLANILAN TIBBİ BİTKİLER

  2020cites this paper
• The Effect of Single or Multiple Doses of Grapefruit Juice on the Analgesic Effect of Ibuprofen in Mice

  2020influential citation
• Review on Preclinical and Clinical Evidence of Food (Beverages, Fruits and Vegetables) and Drug Interactions: Mechanism and Safety

  2020cites this paper
• Interventional Pharmacoeconomics: A Novel Mechanism for Unlocking Value.

  2020cites this paper
• Ciprofloxacin-induced Stevens-Johnson Syndrome with Grapefruit Juice Consumption: A Case Report

  2019cites this paper
• Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin

  2019cites this paper
• Ultra-High-Precision, in-vivo Pharmacokinetic Measurements Highlight the Need for and a Route Toward More Highly Personalized Medicine

  2019cites this paper
• Venetoclax in the treatment of chronic lymphocytic leukemia

  2019cites this paper
• Pharmacokinetic interactions: the effect of herbal extracts and supplements on drug permeation

  2018cites this paper
• Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles

  2018influential citation
• Drug-Drug Interactions and Psychiatric Medication

  2018cites this paper
• Grapefruit and its biomedical, antigenotoxic and chemopreventive properties.

  2018cites this paper
• Selected Food/Herb–Drug Interactions: Mechanisms and Clinical Relevance

  2017cites this paper
• Raw data Polypharmacy in Alzheimer's disease patients in Brazil: Guidance for pharmaceutical assistance

  2017cites this paper
• Polypharmacy in Alzheimer ' s disease patients in Brazil : Guidance for pharmaceutical assistance

  2017cites this paper
• Interactions between Nutraceuticals/Nutrients and Therapeutic Drugs

  2016cites this paper
• CHAPTER 11 – Nutrition, occupational performance, and the phenomenology of food in later life

  2016cites this paper
• Pharmacology: Cultural and Genetic Considerations

  2016cites this paper
• Exogenous sample contamination. Sources and interference.

  2016cites this paper
• Potential drug–drug interactions in Alzheimer patients with behavioral symptoms

  2015cites this paper
• The Effect of Food and Excipients on Drug Pharmacokinetics

  2015cites this paper
• Potential drug–drug interactions in Alzheimer patients with behavioral symptoms

  2015cites this paper
• Clinically Relevant Pharmacokinetic Herb-drug Interactions in Antiretroviral Therapy.

  2015cites this paper
• CYP450 and Its Implications in the Clinical Use of Antipsychotic Drugs

  2015cites this paper
• Evaluation of grapefruit extract for the prevention of paracetamol-induced hepatotoxicity after overdose in rats

  2015cites this paper
• 94 – Histamine and H1 Antihistamines

  2014cites this paper
• Principles of Toxicology

  2014cites this paper
• Hydroxybenzoic acid isomers and the cardiovascular system

  2014cites this paper
• Interactions of Papua New Guinea medicinal plant extracts with antiretroviral therapy.

  2014cites this paper
• Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents

  2014cites this paper
• The Transformer database: biotransformation of xenobiotics

  2013cites this paper
• The Chemoprevention of Chronic Degenerative Disease Through Dietary Antioxidants: Progress, Promise and Evidences

  2013cites this paper
• Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy

  2013cites this paper
• Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens.

  2013cites this paper
• Review of Grapefruit Juice Mediated Drug-Drug Interactions – Trends from a Chirality Perspective

  2013cites this paper
• Fruit/Vegetable-Drug Interactions: Effects on Drug Metabolizing Enzymes and Drug Transporters

  2013cites this paper
• Influence of deoxynivalenol and T-2 toxin on the intestinal barrier and liver function in broiler chickens

  2013cites this paper
• Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants

  2013cites this paper
• Time-dependent changes in hepatic and intestinal induction of cytochrome P450 3A after administration of dexamethasone to rats

  2013cites this paper
• Modeling Chemical Interaction Profiles: I. Spectral Data-Activity Relationship and Structure-Activity Relationship Models for Inhibitors and Non-inhibitors of Cytochrome P450 CYP3A4 and CYP2D6 Isozymes

  2012cites this paper
• Le rôle des cytochromes P450 dans les interactions médicamenteuses et environnementales rencontrées à l'officine

  2012cites this paper
• Histological Alteration of the Cerebellum of Adult Male Wistar Rat Treated with the Grapefruit Extract (Citrus paradisi)

  2012cites this paper
• Interstitial lung damage due to cocaine abuse: pathogenesis, pharmacogenomics and therapy.

  2012cites this paper
• Nutrición en el paciente polimedicado

  2012cites this paper
• Tissue distribution and cytochrome P450 inhibition of sesaminol and its tetrahydrofuranoid metabolites.

  2012cites this paper
• To fast or not to fast? How food could impact on the absorption of kinase inhibitors and its economical value

  2011cites this paper
• Transporter-mediated drug-drug interactions.

  2011cites this paper
• Drug Metabolism in Gastrointestinal Tract

  2011cites this paper
• [Grapefruit consumption and food-drug interaction hazard].

  2011cites this paper
• Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.

  2011cites this paper
• Systemic Exposure to Armodafinil and Its Tolerability in Healthy Elderly versus Young Men

  2011cites this paper
• Relations Between Occurrence of the Risk of Food-Drug Interactions and Patients' Socio-Demographic Characteristics and Selected Nutrition Habits

  2011cites this paper
• Investigating variability in patient response to treatment – a case study from a replicate cross-over study

  2011cites this paper
• Polymorphisms in interstitial lung diseases: Friend or foe.

  2011cites this paper
• Interactions Between Fruit Juices and Drugs

  2010cites this paper
• Toxicology, Safety and Herb–drug Interactions in Cancer Therapy

  2010cites this paper
• CHAPTER 23 – The Pharmacology of Aging

  2010cites this paper
• Functional food ingredients as adjunctive therapies to pharmacotherapy for treating disorders of metabolic syndrome

  2010cites this paper
• STRUCTURAL REQUIREMENTS OF ORGANIC ANION TRANSPORTING POLYPEPTIDE MEDIATED TRANSPORT

  2010cites this paper
• Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions.

  2010cites this paper
• Conference on ‘ Malnutrition matters ’ Symposium 8 : Drugs and nutrition Important drug – nutrient interactions

  2010cites this paper
• Relationship between drug-induced interstitial lung diseases and cytochrome P450 polymorphisms

  2010cites this paper
• INTERNATIONAL HEALTH NEWS

  2010cites this paper
• Race, Medicine, and the Science Behind BiDil: How ACE-Inhibition Took the Fall for the First Ethnic Drug

  2010cites this paper
• Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

  2010cites this paper
• Relationship between drug-induced interstitial lung diseases and CYP polymorphisms

  2010cites this paper
• Herbal interactions with anticancer drugs: mechanistic and clinical considerations.

  2010cites this paper
• Alternative formulations, delivery methods, and administration options for psychotropic medications in elderly patients with behavioral and psychological symptoms of dementia.

  2010cites this paper
• Biotransformation of Xenobiotics

  2009cites this paper
• Making Decisions about the Risks of Chemicals in Foods with Limited Scientific Information

  2009cites this paper
• Grapefruit juice alters plasma sertraline levels after single ingestion of sertraline in healthy volunteers

  2009cites this paper
• Expert Report: Making Decisions about the Risks of Chemicals in Foods with Limited Scientific Information: An IFT Expert Report Funded by the IFT Foundation.

  2009cites this paper
• Drug interactions

  2009cites this paper
• Effects of Citrus Fruit Juices on P-glycoprotein-mediated Transport in L-MDR1 Cells and CYP3A4-mediated Metabolism in Human Intestinal Microsomes

  2008cites this paper
• The Effects of a Naturally Occurring Genetic Polymorphism on the Catalytic Properties of Human Cytochrome P450 2B6.

  2008cites this paper
• Clinically Significant Grapefruit Juice-Drug Interactions

  2008cites this paper
• Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.

  2008cites this paper
• Interactions of polyphenols with the P450 system: possible implications on human therapeutics.

  2008cites this paper
• Activation of pregnane X receptor by Ginkgo biloba extract

  2008cites this paper
• Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.

  2008cites this paper
• The value meal: how to save $1,700 per month or more on lapatinib.

  2007cites this paper
• Metabolism of dietary polyphenols and possible interactions with drugs.

  2007cites this paper
• Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update.

  2007cites this paper
• Food and pain: should we be more interested in what our patients eat?

  2007influential citation
• The value of label recommendations: how to dose lapatinib.

  2007cites this paper
• Orange juice has no effect on CYP 2 D 6-dependent drug metabolism

  2007cites this paper
• Not Geropharmacotherapy 101

  2007cites this paper
• Polypharmacy in Alzheimer's disease patients in Brazil: Guidance for pharmaceutical assistance [version 1; peer review: 1 approved with reservations]

  year unknowncites this paper